FDA's cGMPs for the 21st Century Initiative

Instructor: Betty Jones
Product ID: 700156
Training Level: Intermediate

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-565-8542


Read Frequently Asked Questions

This presentation will provide and insiders view FDA’s path to restructuring its regulatory oversight of manufacturing quality that is based on quality systems and risk management approaches


In 2002, FDA announced a significant new initiative, Current Good Manufacturing Practices (cGMPs) for the 21st Century intended to modernize FDA’s regulation of pharmaceutical quality and established a new regulatory framework for manufacturing.

Implementation of the envisioned new framework and its elements require the use of risk-based and science-based approaches for regulatory decision-making throughout the entire life-cycle of the product.

Areas Covered in the seminar:
  • FDA’s cGMPs for the 21st Century Initiative
  • Background and Scope
  • Fundamental Principle
  • Objectives and Guiding Principles
  • Concepts of Quality Systems and cGMPs
  • cGMP and Quality Systems Comparisons
  • cGMP Compliance
  • Questions
Who Will Benefit:
This webinar will provide valuable assistance to pharmaceutical, device and biologics regulated companies in or transitioning into a cGMP environment. It is also useful as a refresher for companies that wish to stay current with cGMP regulations and FDA’s expectations. The employees who will benefit include:
  • Management
  • Quality Units (Quality Control/Quality Assurance)
  • Production Personnel
  • Internal Auditors
  • Quality Systems Personnel
  • Consultants

Instructor Profile
Betty L. Jones, MPH, is Managing Director/Founder of Comprehensive Compliance Solutions (CCS), a consulting firm specializing in all aspects of regulatory compliance and training to firms that manufacture and market FDA regulated products. Ms. Jones is the former Deputy Director of the Office of Compliance, CDER and a recognized expert in applying and interpreting FDA’s statutes, codes, regulations and standards. She has over 33 years of experience with the FDA directing regulatory and compliance activities in three of FDA’s six components and has experience as a field investigator, a compliance officer, Branch chief and Acting Office Director.

Follow us :
ComplianceOnline Medical Device Summit 2017

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed